Old leprosy drug gets new shot at fighting stubborn lung bug
NCT ID NCT02968212
Summary
This study is testing whether an antibiotic called clofazimine can help treat a persistent lung infection called Mycobacterium avium complex (MAC). 102 adults with MAC lung disease will take either the drug or a placebo for six months to see if it clears the infection from their lungs. Researchers will also check if the treatment improves breathing, energy levels, and overall quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYCOBACTERIUM AVIUM COMPLEX are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Louisiana State University
Baton Rouge, Louisiana, 70803, United States
-
National Heart, Lung and Blood Institute
Bethesda, Maryland, 20814, United States
-
National Jewish Health
Denver, Colorado, 80206, United States
-
Oregon Health & Science University
Portland, Oregon, 97239, United States
-
University of Chicago
Chicago, Illinois, 60637, United States
-
University of South Florida
Tampa, Florida, 33620, United States
-
University of Texas Health Science Center
Tyler, Texas, 75708, United States
Conditions
Explore the condition pages connected to this study.